SYRS - Pambiji Buku Bisnis syros.com

Logo perusahaan publik Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals (SYRS) develops innovative medical products based on DNA technologies, although external conflicts and sanctions create risks for raw material logistics and testing. This market trend, visualized in monetary terms with a value of -0.01, confirms the current price action. High R&D costs and patent protection for biomarkers create significant barriers to entry, while the trial stage temporarily limits the company's ability to exercise pricing power over future medications.

syros.com (SYRS) - Nilai Buku Perusahaan saka 04.07.2022 nganti 29.03.2025
Barang unggulan Syros

To minimize fundamental risks, investors evaluate the real value of net assets, calculated through the daily tracking of equity based on market closes. Amid workforce reductions and stagnating R&D processes at Syros Pharmaceuticals (SYRS), the current book capitalization reflects the liquidity burn rate and the resilience of residual capital in the face of high unit costs.

Pesaing Syros Pharmaceuticals

TEM: Nilai Akuntansi Perusahaan|Qiagen N.V. - Nilai Buku Perusahaan|ionispharma.com (IONS) - Pambiji Buku Bisnis|Kapitalisasi Buku Repligen (RGEN)|Kapitalisasi Akuntansi RNA|Nilai Buku Perusahaan CRISPR Therapeutics Corp CRSP|Kapitalisasi Akuntansi GeneDx Corp (WGS)|Kapitalisasi Buku RARE (Ultragenyx Pharmaceutical)|beamtx.com - Kapitalisasi Buku|Nilai Buku Perusahaan SRPT (Sarepta)|Twist Bioscience Inc (TWST) - Pambiji Buku Bisnis|Aset Bersih Perusahaan TXG|NTLA (Intellia Corp) - Ekuitas Perusahaan|STOK - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan BLFS|Wave Life Sciences Ltd. - Nilai Buku Perusahaan|Ekuitas Perusahaan MAZE (Maze Therapeutics, Inc.)|Nilai Buku Perusahaan SION|PRME - Pambiji Buku Bisnis|Aset Bersih Perusahaan Taysha Gene Therapies (TSHA)|QURE: Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan MeiraGTx (MGTX)|REGENXBIO Inc (RGNX) - Nilai Aset Bersih|SLDB - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Ocugen Pharma|Kapitalisasi Buku PACB|Kapitalisasi Buku BNTC (benitec.com)|Nilai Buku Perusahaan Design Therapeutics, Inc.|Rocket Pharma - Nilai Akuntansi Perusahaan|FDMT: Nilai Buku Perusahaan|LXEO - Aset Bersih Perusahaan|KRRO: Kapitalisasi Buku|editasmedicine.com (EDIT) - Kapitalisasi Buku|Kapitalisasi Buku SLN|Aset Bersih Perusahaan ProQR Therapeutics NV|Codexis, Inc. - Kapitalisasi Buku|Ekuitas Perusahaan Sangamo BioSciences SGMO|Aset Bersih Perusahaan NAUT (Nautilus Bio)|MGX - Kapitalisasi Buku|Aset Bersih Perusahaan Precision BioSciences DTIL|GBIO - Total Aset Bersih|Boundless Bio, Inc - Kapitalisasi Buku|Exicure (XCUR) - Pambiji Buku Bisnis|Kapitalisasi Buku IMNN|Aset Bersih Perusahaan RXi Pharmaceuticals|Kapitalisasi Buku MBIO|Kapitalisasi Buku RNAZ (transcodetherapeutics.com)|Nilai Buku Perusahaan Bionano Genomics BNGO|Applied DNA Corp - Nilai Buku Perusahaan|Nilai Buku Perusahaan BLUE (bluebird bio, Inc.)|IPA: Pambiji Buku Bisnis|Omega Therapeutics, Inc. - Nilai Buku Perusahaan|Pambiji Buku Bisnis Singular Genomics Systems, Inc.|Aset Bersih Perusahaan RGLS (Regulus Therapeutics Inc)|Ekuitas Perusahaan TBIO|TRACON Pharmaceuticals (TCON) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan UBX (unitybiotechnology.com)